| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 467.32B | 476.12B | 473.95B | 469.06B | 395.78B | 376.56B |
| Gross Profit | 72.44B | 87.07B | 70.70B | 64.63B | 57.89B | 57.36B |
| EBITDA | 48.71B | 61.38B | 47.71B | 44.19B | 38.42B | 39.00B |
| Net Income | 28.84B | 40.05B | 28.88B | 28.02B | 26.35B | 26.22B |
Balance Sheet | ||||||
| Total Assets | 463.43B | 523.27B | 488.47B | 503.28B | 446.41B | 378.40B |
| Cash, Cash Equivalents and Short-Term Investments | 75.76B | 51.94B | 71.70B | 98.55B | 67.53B | 40.01B |
| Total Debt | 24.46B | 29.76B | 23.72B | 35.34B | 37.56B | 14.26B |
| Total Liabilities | 148.67B | 171.62B | 176.31B | 212.15B | 183.39B | 137.20B |
| Stockholders Equity | 312.69B | 347.70B | 310.10B | 288.78B | 260.84B | 239.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.21B | 4.80B | 41.95B | 14.32B | 1.11B |
| Operating Cash Flow | 0.00 | 12.33B | 8.66B | 43.97B | 17.39B | 5.25B |
| Investing Cash Flow | 0.00 | -18.16B | -8.93B | -2.34B | -3.13B | -7.56B |
| Financing Cash Flow | 0.00 | -14.29B | -24.53B | -11.01B | 11.64B | -10.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥659.28B | 15.99 | 8.34% | 2.66% | 2.61% | 22.78% | |
78 Outperform | ¥265.36B | 9.89 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥661.42B | 11.33 | ― | 2.15% | 0.46% | 38.67% | |
78 Outperform | ¥1.40T | 17.13 | 14.94% | 2.00% | 10.44% | 50.36% | |
70 Outperform | ¥578.94B | 14.38 | ― | 2.51% | 17.43% | 16.94% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |